Loading…
Held by equity mutual funds in 12 disclosed months, Oct 2025 to Sep 2026.
Rubicon Research Limited (Pharmaceuticals & Biotechnology) was held by 29 active equity mutual funds in September 2026, ₹2,728 Cr in all (up 4 funds from Aug 2026). The largest position was Bajaj Finserv Healthcare Fund at 6.1% of its portfolio. During the month 5 funds entered and 1 exited. Funds have disclosed holding it since Oct 2025.
Weight is the share of that fund's portfolio; change is against the previous disclosed month.
How many equity funds held the company each month, and the value they held.